Physician
Special Care LLC
Special Care LLC was paid $2.01M by Medicaid between Feb 2018 and Dec 2024, across 26 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 59% of everything it billed.
33Billing provider infoSPECIAL CARE LLC
SILVER SPRING, MD 20903
SILVER SPRING, MD 20903
33aNPI1306106596assigned 05/21/2012
33bProvider typeFamily Medicine Physician
28Total paid$2.01M
24GClaims32,761
24DCodes billed26
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Maryland
Rank by total paid#21 of 287
Median peer was paid$78K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43 | $4K | |
| 2019 | 59 | $529.64 | |
| 2020 | 5,086 | $310K | |
| 2021 | 6,010 | $314K | |
| 2022 | 5,902 | $393K | |
| 2023 | 7,351 | $470K | |
| 2024incomplete | 8,310 | $520K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 59% | 14,019 | 8,244 | $1.18M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 7,644 | 5,299 | $662K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 4.1% | 695 | 647 | $83K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.0% | 350 | 338 | $41K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 613 | 458 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,613 | 3,198 | $7K |
| 99335 | <1% | 247 | 129 | $5K | |
| 81000 | <1% | 3,593 | 3,042 | $4K | |
| 99348 | <1% | 132 | 94 | $4K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 176 | 143 | $3K |
| 90661 | <1% | 87 | 82 | $3K | |
| 90688 | <1% | 148 | 134 | $3K |
14 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 181 | $2K |
| 90686 | <1% | 86 | $2K | |
| 90682 | <1% | 36 | $2K | |
| 90674 | <1% | 39 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 28 | $535.50 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 331 | $358.43 |
| 82962 | <1% | 88 | $112.23 | |
| 99000 | <1% | 329 | $85.80 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 175 | $54.41 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 30 | $8.60 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 50 | $0.36 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 44 | $0.00 |
| 90662 | 0% | 12 | $0.00 | |
| 90694 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMACARTHY, ANTHONY (MEDICAL DIRECTOR)